KVHI Form 4: Director David Kagan receives 18,728 restricted shares
Rhea-AI Filing Summary
David B. Kagan, a director of KVH Industries, Inc. (KVHI), received a restricted stock grant of 18,728 shares on 08/21/2025 as board compensation. The grant was recorded at a $0 price and increases Mr. Kagan's reported beneficial ownership to 60,392 shares. The restricted shares vest in four installments on 11/21/2025, 02/21/2026, 05/21/2026 and 08/21/2026, each contingent on Mr. Kagan remaining a KVH board member.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation via restricted stock; aligns director with shareholder interests without immediate cash outlay.
The Form 4 discloses a non-cash restricted stock grant of 18,728 shares to a sitting director, bringing reported beneficial ownership to 60,392 shares. Vesting across four scheduled dates conditions retention of board service, which is a common governance practice to promote continuity and alignment with long-term shareholder value. The grant was reported at $0, indicating it is compensatory rather than a market purchase. This filing appears procedural and not indicative of unusual insider behavior.
TL;DR: Disclosure complies with Section 16 timing; transaction coded as routine grant with specified vesting dates.
The Form 4 identifies the transaction date of 08/21/2025 and was signed on 08/25/2025. The transaction code J(1) denotes a grant or award to a reporting person, and the filing shows the required vesting schedule. All required elements for a Section 16 disclosure are present: reporting person details, security title, number of shares, post-transaction ownership, and the nature and schedule of the restriction. No derivative transactions or dispositions are reported.